Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   



Processing
Collecting data for ^NYA and ACUR ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 NYSE  and   Acura Pharmaceuticals Inc.
Check Correlation Matrix  
Daily Returns (%)
NYA  ACUR  
Timeline
Given investment horizon of 30 days, NYSE is expected to generate 0.28 times more return on investment than Acura. However, NYSE is 3.56 times less risky than Acura. It trades about -0.32 of its potential returns per unit of risk. Acura Pharmaceuticals Inc. is currently generating about -0.19 per unit of risk. If you would invest 807,079 in NYSE on April 24, 2012 and sell it today you would lose (52,989) from holding NYSE or give up 6.57% of portfolio value over 30 days.

Diversification

Very weak diversification
Overlapping area represents amount of risk that can be diversified away by holding NYSE and Acura Pharmaceuticals Inc. in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

0.51
 Parameters
Time Period1 Month [change]
DirectionPositive ACUR Moved Up vs ^NYA
StrengthWeak
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between NYA and ACUR with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between NYA and ACUR to your reader
 
Get social with Correlation between NYA and ACUR
 Share Correlation between NYA and ACUR 
Share Share Correlation between NYA and ACUR
    
    
 
       
Predicted Return Density
Expected Daily Returns   
NYA  ACUR  

NYSE

 
    
    
NYSE
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days NYSE has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
SAP vs. NYSE
Societe Generale Group vs. NYSE
Swiss Reinsurance vs. NYSE
UBS AG vs. NYSE
PETROFAC vs. NYSE
ASML Holding NV vs. NYSE
Berkshire Bancorp Inc. vs. NYSE
SAFRAN vs. NYSE
New Century Bancorp Inc. vs. NYSE
Northern Star Resources Ltd. vs. NYSE
Spark Infrastructure Group vs. NYSE
STANDARD LIFE vs. NYSE
  

Acura Pharmaceuticals Inc.

 
    
    
Acura
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Acura Pharmaceuticals Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Valeant Pharmaceuticals International Inc. vs. Acura Pharmaceuticals Inc.
Elan Corporation plc vs. Acura Pharmaceuticals Inc.
Hospira Inc. vs. Acura Pharmaceuticals Inc.
Alkermes Inc. vs. Acura Pharmaceuticals Inc.
PetMed Express Inc. vs. Acura Pharmaceuticals Inc.
Delcath Systems Inc. vs. Acura Pharmaceuticals Inc.
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting